One of seven senior leaders running the Wealth Management Solutions business. Matrixed organization focused on collaboration and close partnership with legal, compliance, financial planning, technology, marketing, field leadership, etc. First leader on WMS team to embrace Ameriprise India as a source of quantitative, programming, and automation skills, augmenting our robust fundamental research approach.• Provided advisors annually with 2,000 independent and objective, client-approved, research and educational publications, and added social media content which was often in the top 5 out of thousands of pieces available to advisors• Supported WMS product organization with ongoing research and due diligence on over 8,500 investment solutions including funds, ETFs, SMAs, alternative investments, structured products, syndicates, and traditional securities recommendations• Achieved a consistently clean audit record internally and with regulatory agencies• Launched an ongoing series of private label UITs based on our recommended lists, generating $180MM/year in sales

Responsible for recruiting, leading and re-inventing a small group of equity analysts into a holistic research team supporting advisory as well as traditional brokerage business. We added an economist, a market strategist, asset allocation advice, and a team of model portfolio managers. Realigned our industry analysts to a sector approach to provide broader coverage.• Our paper-based model portfolios grew from $250MM to over $20B in client assets by end of year 2023 at Ameriprise• We added proprietary and third-party fund and ETF research to our platform; entrusted with vendor contract negotiation• Appointed as interim president of Olde Asset Management during an approximate 13-month wind-down and outsourcing of the business to Reserve Funds (included team supervision and process oversight for over $3B in client money market assets)• Executive Leadership awarded our team the Model of Excellence Award for our transformative work in advice delivery

Hired as a junior analyst, assisting two senior analysts. Quickly promoted to senior analyst and took on supervisory responsibility for interns and two junior analysts. Provided written research opinions across the health care sector, including pharmaceuticals, biotech, medical devices and supplies, and health care services. Named Wall Street Journal/Zack’s All-Star Analyst, Medical Industry, 1998, ranking 3rd among 39 eligible analysts• Performed fundamental analysis on the health care sector and built financial models to aid in stock valuation, recommendations, and portfolio construction, followed by proactively and concisely communicating perspectives and recommendations to financial advisors via written research• Developed and maintained research relationships with company management, suppliers, and competitors• In charge of department recruiting with final approval by head of research